Currently, Prothena Corporation plc [PRTA] is trading at $15.56, up 2.03%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PRTA shares have gain 12.02% over the last week, with a monthly amount glided 7.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Prothena Corporation plc [NASDAQ: PRTA] stock has seen the most recent analyst activity on December 20, 2024, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $40. Previously, BofA Securities downgraded its rating to Neutral on January 30, 2024, and dropped its price target to $38. On December 12, 2023, Deutsche Bank initiated with a Buy rating and assigned a price target of $62 on the stock. SVB Securities started tracking the stock assigning a Outperform rating and suggested a price target of $80 on April 24, 2023. Piper Sandler initiated its recommendation with a Overweight and recommended $94 as its price target on January 27, 2023. RBC Capital Mkts downgraded its rating to Sector Perform for this stock on November 04, 2022, and upped its price target to $55. In a note dated September 28, 2022, BofA Securities upgraded an Buy rating on this stock.
This stock has fluctuated between a low of $11.70 and a high of $31.03 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $58.5 within the next 12 months. Prothena Corporation plc [NASDAQ: PRTA] shares were valued at $15.56 at the most recent close of the market. An investor can expect a potential return of 275.96% based on the average PRTA price forecast.
Analyzing the PRTA fundamentals
Trailing Twelve Months sales for Prothena Corporation plc [NASDAQ:PRTA] were 135.16M which represents 571.84% growth. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -1.26%, Pretax Profit Margin comes in at -1.05%, and Net Profit Margin reading is -0.99%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.24 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.66 points at the first support level, and at 13.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.56, and for the 2nd resistance point, it is at 17.56.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Prothena Corporation plc [NASDAQ:PRTA] is 10.01. Also, the Quick Ratio is 11.52, while the Cash Ratio stands at 11.19. Considering the valuation of this stock, the price to sales ratio is 6.19, the price to book ratio is 1.72.
